Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharma Two B Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10649
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson’s disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, among others. It provides products for pancreatic, lung and breast cancers, hyperphosphataemia, hyperphosphataemia, hyperlipidemia, secondary hyperparathyroidism and dry eye, among others. Pharma Two formulates products using tableting and microencapsulation techniques. The company develops combinations of two drugs and generic products. It also develops non-infringing formulations and complete research and development files such as formulations, analytical methods, stability, pilot studies, and others. The company markets products in global regions. Pharma Two is headquartered in Rehovot, Israel.

Pharma Two B Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharma Two B Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pharma Two B Raises USD30 Million in Third Round of Financing 10
Pharma Two B Raises US$8 Million In Second Round Of Financing 11
Acquisition 12
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 12
Pharma Two B Ltd – Key Competitors 13
Pharma Two B Ltd – Key Employees 14
Pharma Two B Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Clinical Trials 16
Feb 06, 2018: First Patients Dosed in Phase III Multi-center, Multinational Study to Determine the Efficacy, Safety and Tolerability of P2B001 in Patients with Early Stage Parkinson’s Disease 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharma Two B Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharma Two B Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharma Two B Raises USD30 Million in Third Round of Financing 10
Pharma Two B Raises US$8 Million In Second Round Of Financing 11
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 12
Pharma Two B Ltd, Key Competitors 13
Pharma Two B Ltd, Key Employees 14

List of Figures
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TS Corp (001790):企業の財務・戦略的SWOT分析
    TS Corp (001790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Varian Medical Systems, Inc.:企業の戦略・SWOT・財務情報
    Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cyclopharm Ltd (CYC):医療機器:M&Aディール及び事業提携情報
    Summary Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company’s products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and posi …
  • Cook Medical Inc:企業の製品パイプライン分析
    Summary Cook Medical Inc (Cook Medical), a subsidiary of Cook Group Inc, is a medical device company that develops, manufactures and distributes devices for minimally invasive medicine. The company’s major products include catheters, needles, balloons, grafts, stents, feeding tubes, plugs, wire guid …
  • Insurance Australia Group Limited:企業の戦略・SWOT・財務情報
    Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Allianz Seguros SA:企業の戦略・SWOT・財務分析
    Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report Summary Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • TClarke PLC (CTO):企業の財務・戦略的SWOT分析
    TClarke PLC (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ON Semiconductor Corporation:企業の戦略・SWOT・財務情報
    ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report Summary ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Unfors RaySafe AB:医療機器:M&Aディール及び事業提携情報
    Summary Unfors RaySafe AB (Unfors), formerly Unfors Instruments AB, is a subsidiary of Fluke Biomedical, medical device company that provides solution for the X-ray room consisting of products which collect radiation. The company’s products include RaySafe ThinX, RaySafe X2, RaySafe Solo, RaySafe Xi …
  • Mankind Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mankind Pharma Ltd (MPL) is a manufacturer and supplier of prescriptions medicines, over-the-counter and FMCG products. The company offers prescription medicines in dosage forms of oral solids, oral liquids, soft gelatine capsules and injectables. Its products are used in therapeutic areas o …
  • Powerflute Oy:企業の戦略的SWOT分析
    Powerflute Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • HMicro Inc-医療機器分野:企業M&A・提携分析
    Summary HMicro Inc (HMicro) is a medical device company that offers wireless sensor solutions. The company offers REACH wireless module, a wireless silicon platform that offers fully disposable and wearable wireless sensor patches for a range of professional clinical procedures in hospitals, clinics …
  • Jadason Enterprises Ltd (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Ltd (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tissue Regenix Ltd:企業の製品パイプライン分析
    Summary Tissue Regenix Ltd (Tissue Regenix), a subsidiary of Tissue Regenix Group PLC, is a medical technology company that offers replacement body parts from biological materials by using the dCELL technology platform. The company’s proprietary dCELL technology process is applied in markets such as …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sims Metal Management Ltd:企業の戦略・SWOT・財務情報
    Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Titan Petrochemicals Group Limited (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆